REAL-WORLD CLINICAL CHARACTERISTICS AND TREATMENT PATTERNS IN US PATIENTS WITH RELAPSED/REFRACTORY (R/R) MULTIPLE MYELOMA (MM)

被引：0
|
作者：
Nicacio, L. Viana [1 ]
Calkins, G. [1 ]
Curtis, M. [1 ]
Kohansimeh, J. [1 ]
Lindberg, F. P. [1 ]
Larrabee, K. [1 ]
Jaskiw, A. [1 ]
Feinstein, R. N. [1 ]
Terry, M. [1 ]
Plotkin, L. [1 ]
Palladino, M. L. [1 ]
Krishna, A. [2 ]
Green, R. J. [1 ]
机构：
[1] Flatiron Hlth, New York, NY USA
[2] Novartis Pharmaceut, E Hanover, NJ USA
来源：
HAEMATOLOGICA | 2015年 / 100卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
PB1880
引用
收藏
页码：742 / 742
页数：1
相关论文
共 50 条
  • [1] Recent real-world treatment patterns and outcomes in US patients with relapsed/refractory multiple myeloma
    Bruno, Amanda S.
    Willson, Jenny L.
    Opalinska, Joanna M.
    Nelson, Jeanenne J.
    Lunacsek, Orsolya E.
    Stafkey-Mailey, Dana R.
    Willey, Joanne P.
    [J]. EXPERT REVIEW OF HEMATOLOGY, 2020, 13 (09) : 1017 - 1025
  • [2] Current Real-World Treatment Patterns and Outcomes in Patients with Relapsed/Refractory Multiple Myeloma
    Willson, Jenny
    Bruno, Amanda
    Opalinska, Joanna
    Nelson, Jeannene
    Lunacsek, Orsolya
    Stafkey-Mailey, Dana
    Willey, Joanne
    [J]. BLOOD, 2018, 132
  • [3] Real-World Study of Treatment Patterns in Heavily Pretreated Relapsed/Refractory Multiple Myeloma (RRMM) in the US
    Wang, Peter Feng
    Sansbury, Leah
    DerSarkissian, Maral
    Ferrante, Shannon
    Bhak, Rachel
    Gorsh, Boris
    Zichlin, Miriam L.
    Yee, Christopher W.
    Boytsov, Natalie
    Khanal, Anamika
    Paka, Prani
    Noman, Ahmed
    Duh, Mei Sheng
    [J]. CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2021, 21 : S423 - S423
  • [4] Current real-world treatment patterns and outcomes in patients with relapsed/refractory multiple myeloma.
    Willson, Jenny
    Bruno, Amanda
    Opalinska, Joanna
    Nelson, Jeanenne Joy
    Lunacsek, Orsolya
    Stafkey-Mailey, Dana
    Willey, Joanne P.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [5] Real-World Practice Patterns with Carfilzomib in Patients with Relapsed and Refractory Multiple Myeloma
    Harvey, R. Donald
    Cong, Ze
    Werther, Winifred
    Lethen, Jan L.
    Lonial, Sagar
    [J]. BLOOD, 2014, 124 (21)
  • [6] Real-World Disparities in Daratumumab Utilization for Patients with Relapsed or Refractory Multiple Myeloma (MM)
    Maignan, Kathleen
    Backenroth, Daniel
    McQuarrie, Neil A.
    Lipitz, Nicole G.
    Williams, Erin R.
    Carson, Kenneth R.
    [J]. BLOOD, 2018, 132
  • [7] Real-World Treatment of Patients With Relapsed/Refractory Myeloma
    Ntanasis-Stathopoulos, Ioannis
    Gavriatopoulou, Maria
    Terpos, Evangelos
    Dimopoulos, Meletios A.
    [J]. CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2021, 21 (06): : 379 - 385
  • [8] Real-world treatment patterns in relapsed/refractory multiple myeloma: Clinical and economic outcomes in patients treated with pomalidomide or daratumumab
    Richter, Joshua
    Anupindi, Vamshi Ruthwik
    Yeaw, Jason
    Kudaravalli, Suneel
    Zavisic, Stojan
    Shah, Drishti
    [J]. JOURNAL OF ONCOLOGY PHARMACY PRACTICE, 2022, 28 (02) : 395 - 409
  • [9] REAL-WORLD BORTEZOMIB USAGE PATTERNS AMONG PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA
    Calkins, G.
    Kohansimeh, J.
    Krishna, A.
    Green, R. J.
    Curtis, M.
    Lindberg, F. P.
    Jaskiw, A.
    Larrabee, K.
    Terry, M.
    Feinstein, R. N.
    Plotkin, L.
    Palladino, M. L.
    Nicacio, L. Viana
    [J]. HAEMATOLOGICA, 2015, 100 : 742 - 742
  • [10] REAL-WORLD PRESCRIBING PATTERNS IN US MULTIPLE MYELOMA (MM) PATIENTS REFRACTORY TO LENALIDOMIDE IN THE FRONT-LINE
    Jhaveri, M.
    Romanus, D.
    Raju, A.
    Seal, B.
    Farrelly, E.
    Yong, C.
    Noga, S.
    Labotka, R.
    Blazer, M.
    Parameswaran, H.
    [J]. HAEMATOLOGICA, 2016, 101 : 543 - 544
12345